Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01097811|
Recruitment Status : Unknown
Verified April 2010 by UPECLIN HC FM Botucatu Unesp.
Recruitment status was: Active, not recruiting
First Posted : April 2, 2010
Last Update Posted : April 28, 2010
|Condition or disease||Intervention/treatment||Phase|
|Hepatic Encephalopathy Hypertension, Portal Liver Cirrhosis||Drug: Erythromycin Drug: Neomycin||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Erythromycin Versus Neomycin Treatment for Overt Hepatic Encephalopathy: a Double-blind, Randomised, Controlled Trial.|
|Study Start Date :||June 2008|
|Estimated Primary Completion Date :||June 2010|
|Estimated Study Completion Date :||December 2010|
|Active Comparator: Erythromycin||
250 mg orally q.i.d.
|Active Comparator: Neomycin||
1 g orally q.i.d.
- Recovery of hepatic encephalopathy [ Time Frame: three years ]comparison of efficacy between two drugs for the treatment of hepatic encephalopathy
- length of hospitalization caused by hepatic encephalopathy [ Time Frame: three years ]comparison of efficacy between two drugs for reducing the length of hospitalization during treatment of hepatic encephalopathy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01097811
|Faculdade de Medicina de Botucatu - Universidade Estadual Paulista|
|Botucatu, São Paulo, Brazil, 18618970|
|Principal Investigator:||Fernando G Romeiro||Faculdade de Medicina de Botucatu - UNESP|
|Study Chair:||Carlos A Caramori||Faculdade de Medicina de Botucatu - UNESP|